-
Adefovir: From HBV Mechanism to Translation
2026-08-15
A translational perspective on Adefovir and GS-0393 that connects HBV DNA polymerase inhibition with concentration design, OAT1 transporter studies, clinical pharmacology, and research strategy.
-
Protease Inhibitor Cocktail for NPC Protein Workflows
2026-08-14
Protect TP53- and DHODH-focused lysates from broad proteolysis during Western blot, co-immunoprecipitation, and pathway validation experiments. The separate EDTA component adds metalloprotease coverage but must be removed before metal-affinity workflows.
-
THZ1 Workflow for Transcription Research
2026-08-14
THZ1 combines covalent CDK7 engagement with a practical workflow for connecting RNA polymerase II signaling to cancer-cell proliferation and apoptosis. This guide adapts the super-enhancer logic of a human adipogenesis study into controlled transcription, T-ALL, and cancer biology experiments while clearly separating established evidence from testable extensions.
-
Dual Luciferase Assay System for Gene Regulation
2026-08-13
The Dual Luciferase Reporter Gene System measures firefly and Renilla reporter activity in the same mammalian-cell sample. K1136 supports normalization in gene expression regulation studies through sequential bioluminescence detection and direct reagent addition without a separate pre-assay lysis step.
-
S Tag Peptide: Practical Fusion-Tag Workflows
2026-08-13
S Tag Peptide is a compact, highly soluble peptide sequence used to support recombinant protein detection, antibody-based purification, and protein solubility improvement when genetically fused to a target. It is not a standalone RNase reagent, is insoluble in ethanol, and should be used with short-term solution handling and application-specific validation.
-
AO/PI Double Staining Kit: Practical Workflow
2026-08-12
The AO/PI Double Staining Kit (K2238) provides a rapid fluorescent cell staining workflow for distinguishing green viable cells, orange apoptotic cells, and red membrane-compromised cells. It is useful for a screening-level cell viability assay, but the supplied dossier does not establish it as a standalone method for confirming apoptosis mechanisms or assigning definitive cell-death pathways.
-
Vincristine Sulfate: An Assay-First Research Guide
2026-08-12
Vincristine sulfate is a powerful tool for cancer research, but its value depends on connecting tubulin perturbation to defensible cellular and translational readouts. This assay-first guide explains mechanism, evidence boundaries, preparation, and interpretation without confusing unrelated pharmacology with vincristine biology.
-
Dual Luciferase Reporter Gene System: Mechanism
2026-08-11
Discover how the Dual Luciferase Reporter Gene System converts promoter and enhancer activity into interpretable mechanistic evidence. This guide uses the ZNF263–ULK1 intrahepatic cholangiocarcinoma study to explain assay design, normalization, controls, and translational limitations.
-
Viral RIPK3 Degradation and Inflammation
2026-08-11
Liu et al. identified a cowpox virus and orthopoxvirus factor that hijacks the host SCF machinery to ubiquitinate and degrade RIPK3, thereby suppressing necroptosis. Genetic gain- and loss-of-function experiments in viruses and mice show that this mechanism reshapes viral replication, inflammation, and pathogenicity.
-
ARCA Cy5 EGFP mRNA (5-moUTP) Workflow
2026-08-10
Build a two-channel workflow that separates mRNA uptake from productive translation in mammalian cells. The same fluorescent reporter supports microscopy, flow cytometry, formulation comparisons, and immune-cell delivery studies without secondary RNA staining.
-
FITC-Concanavalin A (ConA) Conjugate Guide
2026-08-09
FITC-Concanavalin A (ConA) Conjugate provides a fluorescence-based approach for detecting accessible α-D-glucose and α-D-mannose residues on cell-surface glycoconjugates. It is suited to immunofluorescence staining and flow cytometry carbohydrate-probe workflows, but not to non-glycan targets or protocols that disregard its light, temperature, and divalent-ion requirements.
-
LARP7–STING Signaling in Diabetic Cardiomyopathy
2026-08-08
The reference study identifies LARP7 as a regulator of glucose-induced diabetic cardiomyopathy by linking its cytoplasmic translocation to impaired STING degradation through the autophagy–lysosomal pathway. Genetic and pharmacological experiments in mice and neonatal cardiomyocytes suggest that targeting LARP7 or STING may reduce cardiac dysfunction, apoptosis, and fibrosis, although translation beyond the experimental model remains unproven.
-
TET2 Metabolite Binding: Protocol and Findings
2026-08-07
This STAR Protocols study presents an orthogonal workflow that combines a flow cytometry-based TET2 activity assay with saturation transfer difference NMR to validate metabolite binding and functional regulation. The approach distinguishes TET2 activators from inhibitors and provides a practical framework for connecting metabolic state with epigenetic enzyme activity.
-
Mc-Val-Cit-PABC-PNP: Practical Guide for ADC Peptide Linker
2026-08-07
Mc-Val-Cit-PABC-PNP addresses the need for a cathepsin B-cleavable peptide linker in antibody-drug conjugate (ADC) synthesis, ensuring selective lysosomal payload release. It is best employed in organic solvent-based workflows and is unsuitable for aqueous, diagnostic, or therapeutic applications.
-
Lycorine Targets ALDH3A1 and FAO to Inhibit Pancreatic Cance
2026-08-06
This study identifies lycorine as a potent inhibitor of pancreatic cancer cell growth by targeting ALDH3A1 and disrupting fatty acid oxidation. Utilizing transcriptomic profiling, functional assays, and in vivo validation, the work provides mechanistic insights and a foundation for targeted therapy research.